miR-155 derived from serum exosomes can promote inflammation in ALI/ARDS by targeting suppressor of cytokine signaling 1(SOCS1) [93], a known target of miR-155 that can inhibit NF-κB activity by reducing the stability of p65. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.